Thermo Fisher Scientific Stock Börse Stuttgart
Equities
TN8
US8835561023
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
528.8 EUR | -0.69% | +2.38% | +10.96% |
Sales 2024 * | 43.02B 39.84B | Sales 2025 * | 46.11B 42.7B | Capitalization | 222B 205B |
---|---|---|---|---|---|
Net income 2024 * | 6.12B 5.66B | Net income 2025 * | 6.92B 6.4B | EV / Sales 2024 * | 5.69 x |
Net Debt 2024 * | 23.19B 21.47B | Net Debt 2025 * | 19.14B 17.72B | EV / Sales 2025 * | 5.23 x |
P/E ratio 2024 * |
36.5
x | P/E ratio 2025 * |
31.3
x | Employees | - |
Yield 2024 * |
0.26% | Yield 2025 * |
0.28% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific
1 week | +2.03% | ||
Current month | +2.03% | ||
1 month | -0.75% | ||
3 months | -3.04% | ||
6 months | +14.88% | ||
Current year | +10.19% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Date | Price | Change |
---|---|---|
24-06-07 | 528.8 | -0.69% |
24-06-06 | 532.5 | +1.25% |
24-06-05 | 525.9 | +0.65% |
24-06-04 | 522.5 | +0.19% |
24-06-03 | 521.5 | +0.62% |
Delayed Quote Börse Stuttgart, June 07, 2024 at 06:48 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.72% | 198B | |
+23.79% | 148B | |
+33.39% | 112B | |
+4.75% | 66.85B | |
+15.59% | 52.84B | |
+3.16% | 50.86B | |
-4.35% | 38.75B | |
-1.27% | 35.15B | |
+22.61% | 31.07B |
- Stock Market
- Equities
- TMO Stock
- TN8 Stock